Cargando…

Down's syndrome, breast cancer and COVID-19

The incidence of cancer in children and adults with Down's syndrome has a clearly differentiated presentation pattern with a higher frequency of lymphomas and leukaemias and a lower frequency of solid tumours. The incidence of breast cancer has especially decreased. In our setting, COVID-19 mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Lara Álvarez, Miguel Ángel, Martín Marino, Almudena, Pérez Pérez, Mar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier España, S.L.U. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413111/
http://dx.doi.org/10.1016/j.mcpsp.2020.100153
_version_ 1783568740160372736
author Lara Álvarez, Miguel Ángel
Martín Marino, Almudena
Pérez Pérez, Mar
author_facet Lara Álvarez, Miguel Ángel
Martín Marino, Almudena
Pérez Pérez, Mar
author_sort Lara Álvarez, Miguel Ángel
collection PubMed
description The incidence of cancer in children and adults with Down's syndrome has a clearly differentiated presentation pattern with a higher frequency of lymphomas and leukaemias and a lower frequency of solid tumours. The incidence of breast cancer has especially decreased. In our setting, COVID-19 mortality in cancer patients has greatly increased. We present the case of a patient with Down's syndrome, breast cancer and COVID-19.
format Online
Article
Text
id pubmed-7413111
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Author(s). Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-74131112020-08-10 Down's syndrome, breast cancer and COVID-19 Lara Álvarez, Miguel Ángel Martín Marino, Almudena Pérez Pérez, Mar Medicina Clínica Práctica Clinical Report The incidence of cancer in children and adults with Down's syndrome has a clearly differentiated presentation pattern with a higher frequency of lymphomas and leukaemias and a lower frequency of solid tumours. The incidence of breast cancer has especially decreased. In our setting, COVID-19 mortality in cancer patients has greatly increased. We present the case of a patient with Down's syndrome, breast cancer and COVID-19. The Author(s). Published by Elsevier España, S.L.U. 2020 2020-08-07 /pmc/articles/PMC7413111/ http://dx.doi.org/10.1016/j.mcpsp.2020.100153 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Clinical Report
Lara Álvarez, Miguel Ángel
Martín Marino, Almudena
Pérez Pérez, Mar
Down's syndrome, breast cancer and COVID-19
title Down's syndrome, breast cancer and COVID-19
title_full Down's syndrome, breast cancer and COVID-19
title_fullStr Down's syndrome, breast cancer and COVID-19
title_full_unstemmed Down's syndrome, breast cancer and COVID-19
title_short Down's syndrome, breast cancer and COVID-19
title_sort down's syndrome, breast cancer and covid-19
topic Clinical Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413111/
http://dx.doi.org/10.1016/j.mcpsp.2020.100153
work_keys_str_mv AT laraalvarezmiguelangel downssyndromebreastcancerandcovid19
AT martinmarinoalmudena downssyndromebreastcancerandcovid19
AT perezperezmar downssyndromebreastcancerandcovid19